Patents by Inventor Rebecca DEPREZ POULAIN

Rebecca DEPREZ POULAIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ERAP INHIBITORS
    Publication number: 20240101542
    Abstract: The present disclosure relates to novel compounds of formula (I) which are useful as inhibitors of endoplasmic reticulum aminopeptidases (ERAP), in particular as inhibitors of ERAP2. The disclosure also relates to the therapeutic use of these compounds, in particular the use of these compounds in the treatment or prophylaxis of proliferative disorders, autoinflammatory disorders and autoimmune disorders.
    Type: Application
    Filed: December 17, 2021
    Publication date: March 28, 2024
    Inventors: Rebecca DEPREZ POULAIN, Ronan GEALAGEAS, Virgyl CAMBERLEIN, Charlotte TABEY FLEAU, Valentin GUILLAUME, Damien BOSC, Benoit DEPREZ, Pierre SIEROCKI
  • 5-MEMBERED HETEROARYL COMPOUNDS CONTAINING A HYDROXAMATE MOIETY AND THEIR USE
    Publication number: 20220073475
    Abstract: The present invention is directed to 5-membered heteroaryl compounds containing a hydroxamate moiety of Formula I, pharmaceutically acceptable salts or solvates thereof, and their use as sensitizers for chemotherapy of malignant tumors.
    Type: Application
    Filed: January 16, 2020
    Publication date: March 10, 2022
    Inventors: Rebecca DEPREZ POULAIN, Benoit DEPREZ, Florence LEROUX, Damien BOSC, Ronan GEALAGEAS, Jouda JAKHLAL, Peter VAN ENDERT, Nathalie HENNUYER, Bart STAELS